SynthesisMalaria journal2026

Evaluating the safety, pharmacokinetics, and antiparasitic activity of DSM265, a novel antimalarial plasmodium dihydroorotate dehydrogenase inhibitor: a systematic review and meta-analysis of early clinical trials.

Idris Sula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.